AAArwa Z. Al-Riyami

Arwa Z. Al-Riyami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Arwa Z. Al-Riyami has a total of 708 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Co‐design with community partners in blood donor recruitment: A global assessment

    by Richard Mills, Arwa Z. Al‐Riyami, Jeannie Callum, Abiola Okubanjo, Christopher Bocquet, Barbara Masser, Eva‐Maria Merz, Eamonn Ferguson

    Background: Blood services need to increase representativeness of donors from ethnically diverse communities, yet evidence‐based recruitment strategies remain scarce. Co‐design with community partners is a promising approach to developing culturally resonant materials, but the extent of its use globally remains unknown. Study Design and Methods: We surveyed transfusion professionals registered with the Association for the Advancement of Blood and Biotherapies (AABB) and the International Society of Blood Transfusion (ISBT). Respondents reported recruitment methods in general use and ranked their perceived effectiveness. We then examined the adoption of co‐design specifically for ethnically diverse donor recruitment, including attitudes, barriers, and evaluation. Results: Of 170 respondents across four regions (Europe, North America, South‐East‐Asia, Rest‐of‐the‐World), 94% reported that their institution actively recruited blood donors, and 51% identified they had a critical need for ethnically diverse supplies. Co‐design was used by 33% of active recruiters, ranking seventh of 11 methods. Among those stating a critical need: 73% had developed ethnically tailored materials, 38% had used co‐design, 13% co‐designed videos, and 11% evaluated co‐designed video effectiveness. Attitudes were favorable regardless of critical‐need status, with 82%–89% endorsing bespoke videos as effective. Barriers were predominantly resource‐based: funding (54%–57%), media‐production expertise (29%–35%), and co‐design expertise (24%–36%). Discussion: Co‐design for ethnically diverse donor recruitment is underused, revealing a belief–practice gap: attitudes are favorable, but adoption is low. Barriers are resource‐based rather than attitudinal, and evaluation is rare. Wider adoption depends on building organizational capacity: funding, co‐design expertise, and embedding evaluation from the outset.

  • International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Responses

    by Champa Manchanayake, Jennie Haw, Shun Yin Kong, Cheuk Kwong Lee, Janaki Dissanayake, Trilitia Withanawasam, Ramir M. Alcantara, Kalinga Perera, Maha A. Badawi, Eman M. Mansory, et al.

  • International Forum on the Management of Donors Following Recurrent Quality Monitoring System Failures and Subsequent Discards: Summary

    by Champa Manchanayake, Jennie Haw, Shun Yin Kong, Cheuk Kwong Lee, Janaki Dissanayake, Trilitia Withanawasam, Ramir M. Alcantara, Kalinga Perera, Maha A. Badawi, Eman M. Mansory, et al.

  • International Forum on the Prevention of ABO Incompatible Red Blood Cell Transfusion: Summary

    by Aline Mirrione‐Savin, Michael F. Murphy, Richard Schäfer, Pierre Tiberghien, Satyam Arora, Seema Dua, Markus M. Mueller, Torsten Tonn, Saliou Diop, Moussa Seck, et al.

  • International Forum on the Prevention of ABO Incompatible Red Blood Cell Transfusion: Responses

    by Aline Mirrione‐Savin, Michael F. Murphy, Richard Schäfer, Pierre Tiberghien, Satyam Arora, Seema Dua, Markus M. Mueller, Torsten Tonn, Saliou Diop, Moussa Seck, et al.

  • Open Access

    A global survey of blood transfusion practices for patients with sickle cell disease

    by Jeremy W. Jacobs, Arwa Z. Al‐Riyami, Jeannie Callum, Meghan Delaney, David Daniel, Jenny White, Christopher Bocquet, Mohammed Farouk, Claude Tayou, Chinelo P. Onyenekwu, et al.

    Background: Sickle cell disease (SCD) affects over 7 million people globally, with blood transfusion remaining a cornerstone of management. However, contemporary transfusion practices across diverse settings remain poorly characterized. We evaluated global transfusion practices for patients with SCD to identify gaps and inform resource prioritization. Study Design and Methods: We conducted a cross‐sectional web‐based survey of clinicians and laboratory professionals providing transfusion support for SCD, distributed via email using three professional society's membership lists (July–September 2025). Variables included facility characteristics, pre‐transfusion testing capabilities, antigen‐matching strategies, transfusion modalities, and barriers to care, stratified by World Bank income classification. Results: After excluding incomplete/duplicate responses, 102 facilities from 39 countries were analyzed; 95 actively treated patients with SCD. Facilities were predominantly public (73%), with 46% in lower‐middle‐income countries (LMICs). Routine newborn screening was performed by 33% overall (48% high‐income countries [HICs] vs. 0% low‐income). While ABO/RhD typing was nearly universal, antibody screening was available in only 72% of facilities (0% low‐income, 47% LMICs, 98% HICs). Prophylactic RBC antigen matching was performed by 46% (18% LMICs vs. 70% HICs), primarily limited to Rh(CcEe) and K. Automated RBC exchange was available in 44% overall (0% low‐income, 25% LMICs, 73% HICs); among facilities with exchange capability, 83% of HICs versus 36% of LMICs could provide exchange within 24 h for acute indications. Discussion: Pronounced income‐related disparities exist in SCD transfusion support. Facilities in lower‐income settings disproportionately lack antibody testing, prophylactic matching, and timely automated exchange. Targeted infrastructure investment and context‐appropriate guidelines are essential for equitable care.

  • Open Access

    From Classroom to Cleanroom: Building a Skilled Cell and Gene Therapy Workforce

    by Ali Shokoohmand, Eddie Hp Tan, Arwa Z. Al-Riyami, Anna Koptina, Colleen Richards, Mariana Morato-Marques, Piriya Yoganathan, Nouf Al-Rasheed, Gemma Moir-Meyer, Nikita M. Patel, et al.


  • Open Access

    Adaptive admixture at ACKR1, the Duffy blood group locus, may have shaped Plasmodium vivax prevalence in Oman

    by Paige E. Haffener, Arwa Z. Al-Riyami, Shoaib Al-Zadjali, George B.J. Busby, Sulaiman Al-Mahdhuri, Mohammed Al-Rawahi, Saif Al-Hosni, Ali Al-Marhoobi, Ammar Al-Sheriyani, Ellen M. Leffler


  • Artificial intelligence in transfusion medicine: Soon the end of the beginning?

    by Arwa Z. Al‐Riyami, Pierre Tiberghien

  • Use of artificial intelligence in transfusion medicine practice, education and research: A mixed methodology study

    by Arwa Z. Al‐Riyami, Karl Rexer, Ken Masters, Richard Gammon

    Background and Objectives: The artificial intelligence (AI) field holds significant promise to revolutionize healthcare, including transfusion medicine (TM). This study explored AI use in TM, education and research among International Society of Blood Transfusion (ISBT) members. Materials and Methods: A mixed methodology was employed. A survey was conducted June to November 2024. Eighteen participants were interviewed. Results: A total of 218 ISBT members from 67 countries responded to the survey, 43.5% of which use AI. Most users (91.1%) have used Generative AI (GenAI); 82.3% indicated they were self‐taught. Application to clinical TM was reported by 54.4%, and 87.3% reported a positive impact. A third of respondents (32.7%) indicated the use of AI in their institutions, commonly GenAI tools. More than two‐thirds indicated use in TM education, research or both, and 71.1% indicated a positive impact on their institution's operations. Use in education included preparing lectures and generating questions. Use in research included brainstorming ideas, statistical analysis, coding, data interpretation, manuscript drafting and proofing. Survey respondents reported various challenges in adopting AI, including lack of access to AI resources or expertise (78%), cost (74%), difficulty in hiring AI professionals (73%) and data privacy concerns (72%). Concerns raised during interviews included accuracy of information, regulatory constraints and risks on intellectual ability and employment. Conclusion: There is general interest in the use of AI in TM practice, education and research. Barriers to adoption include access to the technology and lack of AI professionals. Educational resources must be expanded. Regulatory constraints and privacy and trust concerns need to be addressed.